You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 12, December 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Letters to the Editor
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Head & Neck Cancer
 •Neoplasms of Head & Neck
 •Psychiatry
 •Depression
 •Psychopharmacology
 •Quality of Life
 •Statistics and Research Methods
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Misleading Report on the Prevention of Major Depression Among Patients With Head and Neck Cancer

James C. Coyne, PhD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The abortive clinical trial by Lydiatt et al1 evaluating the use of antidepressants for the prevention of major depression among patients with head and neck cancer is misleading and a travesty in terms of the presentation and interpretation of its results. The upbeat conclusion provided in the abstract has been widely disseminated in the media but should be disqualified because the study was stopped prematurely, intent-to-treat analyses were not conducted, and nonsignificant findings were obtained for the primary outcome.

The incidence of major depression in patients with head and neck cancer is not well documented, but a report stating that 5 of 10 patients in the placebo group developed major depression strains credibility, particularly when readers are not provided with confidence intervals. Lydiatt and colleagues ignored the lack of positive results in previous studies that provided antidepressants to patients with cancer who were selected because they . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

A Randomized, Placebo-Controlled Trial of Citalopram for the Prevention of Major Depression During Treatment for Head and Neck Cancer
William M. Lydiatt, David Denman, Dennis P. McNeilly, Susan E. Puumula, and William J. Burke
Arch Otolaryngol Head Neck Surg. 2008;134(5):528-535.
ABSTRACT | FULL TEXT  

Collaborative Care for Depression: A Cumulative Meta-analysis and Review of Longer-term Outcomes
Simon Gilbody, Peter Bower, Janine Fletcher, David Richards, and Alex J. Sutton
Arch Intern Med. 2006;166(21):2314-2321.
ABSTRACT | FULL TEXT  

RELATED LETTER

Misleading Report on the Prevention of Major Depression Among Patients With Head and Neck Cancer—Reply
William M. Lydiatt and William J. Burke
Arch Otolaryngol Head Neck Surg. 2008;134(12):1345-1346.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.